Using Self-Aware Agilent InfinityLab LC/MSD iQ to Measure Trace-Level Impurities in a Brand Versus Generic Medication

contributed by Agilent Technologies | 01/22/2020

Abstract

This study presents a method for comparison of related impurities in a brand and a generic over-the-counter (OTC) acetaminophen drug. The workflow comprised an Agilent InfinityLab liquid chromatography/mass selective detector (LC/MSD iQ) and an Agilent 1290 Infinity II LC. The study identified impurities at concentrations lower than can be reliably detected by UV.

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.